ETON vs SYK · rev $61.9M vs P/E 35, rev $6.59B
Eton Pharmaceuticals Inc (ETON) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Eton Pharmaceuticals Inc (ETON) is a drug manufacturers - specialty & generic company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported ETON revenue for 2026-06-30 was $61.9M. Net income was $13.1M. ETON currently screens at market cap $797.9M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
ETON currently screens at market cap $797.9M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the ETON and SYK stock pages for the full models.
Not investment advice.